SELLAS Life Sciences Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SELLAS Life Sciences Group generated cash of -$31,410,000, which is less than the previous year. Cash used in financing activities reached the amount of $22,315,000 last year. Net change in cash is therefore -$14,595,000.
Cash Flow
| 2014 | -42.86M | -5.52M | 24.26M |
|---|---|---|---|
| 2015 | -48.16M | 10.39M | 43.84M |
| 2016 | -44.91M | -1.05M | 34.32M |
| 2017 | -10.98M | 1.81M | 5.53M |
| 2018 | -30.42M | 0 | 23.12M |
| 2019 | -17.64M | 0 | 19.56M |
| 2020 | -10.41M | 0 | 38.44M |
| 2021 | -26.02M | 0 | 12.07M |
| 2022 | -23.80M | -4.5M | 24.07M |
| 2023 | -31.41M | -5.5M | 22.31M |
SLS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.22M | 21.45M | 35.40M | 7.37M | 5.45M | 12.75M | 5.96M | 29.73M | 23.65M | 47.78M |
Operating activities | ||||||||||
Net income | -37.34M | -41.30M | -20.69M | -16.75M | -19.29M | -27.67M | -23.75M | -11.10M | -38.95M | -36.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 457K | 5.68M | 282K | 1.69M | 3.75M | 0 | 142K | 355K | 889K |
Stock-based compensation expense | 1.39M | 1.72M | 1.01M | 578K | 573K | 395K | 3.16M | 2.26M | 1.93M | 5.38M |
| Deferred income tax benefit | 1.39M | 1.72M | 1.01M | 578K | 573K | 395K | 3.16M | 2.26M | 1.93M | 5.38M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.7M | 0 | 1.64M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -269K |
Accounts payable | 2.30M | 1.21M | -2.51M | -836K | 12K | -7.93M | 8.36M | -757K | -289K | -389K |
Cash generated by operating activities | -31.41M | -23.80M | -26.02M | -10.41M | -17.64M | -30.42M | -10.98M | -44.91M | -48.16M | -42.86M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -4.5M | 0 | 0 | 0 | 0 | 0 | -6K | -153K | -5.52M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 1.81M | 0 | 0 | 0 |
Cash generated by investing activities | -5.5M | -4.5M | 0 | 0 | 0 | 0 | 1.81M | -1.05M | 10.39M | -5.52M |
Financing activities | ||||||||||
Common Stock Issued | 22.22M | 23.99M | 12.07M | 29.59M | 15.97M | 21.56M | 6.00M | 33.62M | 47.72M | 10.96M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -487K | -675K | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -7.60M | -473K | -5.57M | -3.91M | -1.76M |
Cash used in financing activities | 22.31M | 24.07M | 12.07M | 38.44M | 19.56M | 23.12M | 5.53M | 34.32M | 43.84M | 24.26M |
Net Change In Cash | -14.59M | -4.23M | -13.94M | 28.02M | 1.92M | -7.29M | -3.64M | -11.64M | 6.08M | -24.13M |
Cash at end of period | 2.63M | 17.22M | 21.45M | 35.40M | 7.37M | 5.45M | 2.31M | 18.08M | 29.73M | 23.65M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |